NSE · SPARC
Sun Pharma Advanced Research Company Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#726
of 5,072 stocks
▲ 321W
Peak #726 · 27 Sep 2026
Operating in Healthcare, Sun Pharma Advanced Research Company Limited trades at an undemanding earnings multiple, is growing revenue rapidly, and generates a high return on equity.
Market Cap
6,783.67 Cr
P/E Ratio
4.37
P/B Ratio
5.07
ROE
116.01%
ROCE
112.90%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 39.92 Cr | 1,853.22 Cr | 8.45 Cr | 7.86 Cr |
| Net Profit | -20.78 Cr | 1,761.34 Cr | -80.42 Cr | -75.85 Cr |
| EPS | -0.64 | 54.27 | -2.48 | -2.34 |
| Operating Profit | -12.54 Cr | 1,772.60 Cr | -59.21 Cr | -68.27 Cr |
Shareholding pattern
Promoter
65.67%
Public
34.33%
Mutual fund holdings
₹5.92
Cr total
6
Schemes
4
Fund Houses
₹5.92 Cr
Total Exposure
Motilal Oswal Mutual Fund₹4.94 Cr (83.4%)
Samco Mutual Fund₹0.95 Cr (16.0%)
Groww Mutual Fund₹0.03 Cr (0.6%)
Mirae Asset Mutual Fund₹0.00 Cr (0.1%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 21 Sep 2021 | Other | Annual General Meeting |
| 22 Sep 2020 | Other | Annual General Meeting |
| 18 Jul 2019 | Other | Annual General Meeting |
| 19 Jul 2018 | Other | Annual General Meeting |
| 27 Jul 2017 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.